High STMN1 Expression is Associated with Cancer Progression and Chemo-Resistance in Lung Squamous Cell Carcinoma

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Annals of Surgical Oncology

• Publication date

  2017-09-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1245/s10434-017-6083-0PMID 28933054
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prognostic impact of stathmin 1 expression in patients with lung adenocarcinoma

  2017cited by this paper
• Caspase14 expression is associated with triple negative phenotypes and cancer stem cell marker expression in breast cancer patients

  2017cited by this paper
• High expression of nucleobindin 2 is associated with poor prognosis in gastric cancer

  2017cited by this paper
• Stathmin1 expression is associated with aggressive phenotypes and cancer stem cell marker expression in breast cancer patients

  2017cited by this paper
• High STMN1 level is associated with chemo-resistance and poor prognosis in gastric cancer patients

  2017cited by this paper
• K-RAS mutations indicating primary resistance to crizotinib in ALK-rearranged adenocarcinomas of the lung: Report of two cases and review of the literature.

  2016cited by this paper
• Nuclear PRMT1 expression is associated with poor prognosis and chemosensitivity in gastric cancer patients

  2016cited by this paper
• High Expression of MRE11-RAD50-NBS1 Is Associated with Poor Prognosis and Chemoresistance in Gastric Cancer.

  2016cited by this paper
• Retrospective analysis of second-line chemotherapy outcomes with paclitaxel or docetaxel in correlation with STMN1 polymorphism in advanced non-small cell lung cancer patients

  2015cited by this paper
• Stathmin and phospho-stathmin protein signature is associated with survival outcomes of breast cancer patients

  2015cited by this paper
• Nuclear PROX1 is Associated with Hypoxia-Inducible Factor 1α Expression and Cancer Progression in Esophageal Squamous Cell Carcinoma

  2015cited by this paper
• Overexpression of stathmin is resistant to paclitaxel treatment in patients with non-small cell lung cancer

  2015cited by this paper
• The prognostic value and therapeutic target role of stathmin-1 in urinary bladder cancer

  2014cited by this paper
• Stathmin destabilizing microtubule dynamics promotes malignant potential in cancer cells by epithelial-mesenchymal transition.

  2014cited by this paper
• Stathmin in pancreatic neuroendocrine neoplasms: a marker of proliferation and PI3K signaling

  2014cited by this paper
• Stathmin Protein Level, a Potential Predictive Marker for Taxane Treatment Response in Endometrial Cancer

  2014cited by this paper
• Stathmin regulates mutant p53 stability and transcriptional activity in ovarian cancer

  2014cited by this paper
• Stathmin overexpression identifies high risk for lymphatic metastatic recurrence in pN0 esophageal squamous cell carcinoma patients

  2014cited by this paper
• Stathmin1 regulates p27 expression, proliferation and drug resistance, resulting in poor clinical prognosis in cholangiocarcinoma

  2014cited by this paper
• Biomarker changes associated with the development of resistance to aromatase inhibitors (AIs) in estrogen receptor-positive breast cancer.

  2014cited by this paper
• Stathmin regulates mutant p53 stability and transcriptional activity in ovarian cancer

  2013cited by this paper
• Stathmin-1 Expression as a Complement to p16 Helps Identify High-grade Cervical Intraepithelial Neoplasia With Increased Specificity

  2013cited by this paper
• Nuclear karyopherin-α2 expression in primary lesions and metastatic lymph nodes was associated with poor prognosis and progression in gastric cancer.

  2013cited by this paper
• Stathmin1 overexpression associated with polyploidy, tumor‐cell invasion, early recurrence, and poor prognosis in human hepatoma

  2010cited by this paper
• Targeting Angiogenesis with Multitargeted Tyrosine Kinase Inhibitors in the Treatment of Non-Small Cell Lung Cancer

  2010cited by this paper
• Overexpression of stathmin1 in the diffuse type of gastric cancer and its roles in proliferation and migration of gastric cancer cells

  2010cited by this paper
• The role of microtubules in cell biology, neurobiology, and oncology /

  2008cited by this paper
• EGFR mutations predict survival benefit from gefitinib in patients with advanced lung adenocarcinoma: a historical comparison of patients treated before and after gefitinib approval in Japan.

  2008cited by this paper
• p27Kip1-stathmin interaction influences sarcoma cell migration and invasion

  2005cited by this paper
• p27(Kip1)-stathmin interaction influences sarcoma cell migration and invasion.

  2005cited by this paper
• Effect of stathmin on the sensitivity to antimicrotubule drugs in human breast cancer.

  2002cited by this paper
• Dissociation of the tubulin-sequestering and microtubule catastrophe-promoting activities of oncoprotein 18/stathmin.

  1999cited by this paper
• The stathmin phosphoprotein family: intracellular localization and effects on the microtubule network.

  1998cited by this paper

• Identification of novel long non-coding RNA involved in Sertoli cell of non-obstructive azoospermia based on microarray and bioinformatics analysis.

  2025cites this paper
• On the Ocean of Biomarkers for the Precise Diagnosis and Prognosis of Lung Diseases

  2025cites this paper
• Novel therapeutic strategy targeting STMN1 using chlorambucil‐conjugated pyrrole–imidazole polyamide in small cell lung cancer

  2025cites this paper
• Stathmin 1 expression in neuroendocrine and proliferating prostate cancer

  2025cites this paper
• STMN1在肿瘤中作用的研究进展

  2025cites this paper
• The UALCAN and GEPIA Analyses of the TCGA Database Show a Strong Association Between Increased Expression of Stathmin 1 in Adrenocortical Carcinoma Tissues and Patient Survival

  2025cites this paper
• Quantum Annealing for Enhanced Feature Selection in Single-Cell RNA Sequencing Data Analysis

  2024cites this paper
• Single-cell and spatial transcriptomics reveal a high glycolysis B cell and tumor-associated macrophages cluster correlated with poor prognosis and exhausted immune microenvironment in diffuse large B-cell lymphoma

  2024cites this paper
• Unraveling the Molecular Complexity of Adenoid Cystic Carcinoma (ACC): A Comprehensive Exploration of Hub Genes, Protein-Protein Interaction (PPI) Networks, microRNA (miRNA) Involvement, and Drug-Gene Interactions (DGIs)

  2024cites this paper
• Novel application of the ferroptosis-related genes risk model associated with disulfidptosis in hepatocellular carcinoma prognosis and immune infiltration

  2024cites this paper
• STMN1 Promotes Tumor Metastasis in Non-small Cell Lung Cancer Through Microtubule-dependent And Nonmicrotubule-dependent Pathways

  2024cites this paper
• STMN1表达与非小细胞肺癌预后价值的meta分析

  2024influential citation
• The role of cell cycle-related genes in the tumorigenesis of adrenal and thyroid neuroendocrine tumors

  2024cites this paper
• Stathmin 1 Expression in Neuroendocrine and Proliferating Prostate Cancer

  2024cites this paper
• Modulation of signature cancer-related genes in oral cancer cells (Ca9-22) by anethole treatment: Insights into therapeutic potential

  2024cites this paper
• Biological roles of THRAP3, STMN1 and GNA13 in human blood cancer cells

  2024cites this paper
• Isoform switching leads to downregulation of cytokine producing genes in estrogen receptor positive breast cancer

  2023cites this paper
• The effect of propofol on chemosensitivity of paclitaxel in cervical cancer cells

  2023cites this paper
• A modified natural small molecule inhibits triple-negative breast cancer growth by interacting with Tubb3.

  2023cites this paper
• STNM1 in human cancers: role, function and potential therapy sensitizer.

  2023cites this paper
• Transcriptomic analysis of cutaneous squamous cell carcinoma reveals a multi-gene prognostic signature associated with metastasis.

  2023cites this paper
• STMN1 promotes cell malignancy and bortezomib resistance of multiple myeloma cell lines via PI3K/AKT signaling

  2023cites this paper
• High Tumoral STMN1 Expression Is Associated with Malignant Potential and Poor Prognosis in Patients with Neuroblastoma

  2023cites this paper
• Hsa_circ_0119412 is a tumor promoter in hepatocellular carcinoma by inhibiting miR-526b-5p to upregulate STMN1

  2023cites this paper
• A Five-Gene Signature Associated With DNA Damage Repair Molecular Subtype Predict Overall Survival for Hepatocellular Carcinoma

  2022cites this paper
• STMN1 promotes the proliferation and inhibits the apoptosis of acute myeloid leukemiacells by activating the PI3K/Akt pathway

  2022cites this paper
• Protein Phosphatase 1 Subunit PPP1R14B Stabilizes STMN1 to Promote Progression and Paclitaxel Resistance in Triple-Negative Breast Cancer

  2022cites this paper
• STMN2 overexpression promotes cell proliferation and EMT in pancreatic cancer mediated by WNT/β-catenin signaling

  2022cites this paper
• Long non-coding RNAs involved in retinoblastoma

  2022cites this paper
• Construction of a combined random forest and artificial neural network diagnosis model to screening potential biomarker for hepatoblastoma

  2022cites this paper
• STMN1 as a novel prognostic biomarker in HCC correlating with immune infiltrates and methylation

  2022cites this paper
• Anti-proliferative effect and underlying mechanism of ethoxy-substituted phylloquinone (vitamin K1 derivative) from Spinacia oleracea leaf and enhancement of its extractability using radiation technology

  2022cites this paper
• Overexpression of Stathmin 1 Predicts Poor Prognosis and Promotes Cancer Cell Proliferation and Migration in Ovarian Cancer

  2022cites this paper
• Identification of novel transcription factor-microRNA-mRNA co-regulatory networks in pulmonary large-cell neuroendocrine carcinoma

  2021cites this paper
• Mining the plasma-proteome associated genes in patients with gastro-esophageal cancers for biomarker discovery

  2021cites this paper
• Acquired resistance to PRMT5 inhibition induces concomitant collateral sensitivity to paclitaxel

  2021cites this paper
• PTEN loss promotes oncogenic function of STMN1 via PI3K/AKT pathway in lung cancer

  2021cites this paper
• Distinctive roles of syntaxin binding protein 4 and its action target, TP63, in lung squamous cell carcinoma: a theranostic study for the precision medicine

  2020cites this paper
• Syntaxin binding protein 4 as a novel therapeutic target and an effective biomarker for better treatment selection in lung squamous cell carcinoma: A theranostic study

  2020cites this paper
• Characterization of Leading Dysregulated Plasma-Proteome Associated Genes in Patients with Gastro-Esophageal Cancers.

  2020cites this paper
• Integrated analysis of the roles and prognostic value of RNA binding proteins in lung adenocarcinoma

  2020cites this paper
• Stathmin-1 Is a Useful Diagnostic Marker for High-Grade Lung Neuroendocrine Tumors.

  2019cites this paper
• Association of STMN1 with survival in solid tumors: A systematic review and meta-analysis

  2019cites this paper
• Expression and prognostic analyses of ITGA11, ITGB4 and ITGB8 in human non-small cell lung cancer

  2019cites this paper
• Differential molecular markers of primary lung tumors and metastatic sites indicate different possible treatment selections in patients with metastatic lung adenocarcinoma

  2018cites this paper
• Identi�cation of Novel Transcription Factor-microRNA-mRNA Co-regulatory Networks in Pulmonary Large-cell Neuroendocrine Carcinomas

  year unknowncites this paper